In the early days of the COVID-19 pandemic, tens of thousands of young volunteers offered to risk their health by letting scientists intentionally infect them with the pandemic coronavirus, hoping to speed the hunt for a vaccine or treatment. Several research groups announced plans to run these so-called human challenge trials, even as some scientists questioned whether they could be conducted ethically. Now, with recent news that conventional human trials have produced several promising vaccines, scientists are debating whether planned challenge trials are still needed. In the United States, one nascent effort is on hold. In the United Kingdom, however, researchers say they are moving ahead. To read the full story.
Recent Posts
- NJACTS Community Engagement Core COVID-19 Resources
- N.J. Gov. Phil Murphy urges microplastics regulations in tap water. Can water providers meet the challenge?
- Could Hidden Infections Be Fueling Long COVID?
- Join NJ ACTS BERD on 1/22 for a Workshop with Dr. Yan Sun from NJIT
- How NJIT Graduate Student Jaimee Diogo Is Transforming STEM Futures Through ‘STEM Like a Girl’
Categories
- Community (2,427)
- Covid (996)
- CTO Events (6)
- News (3,073)
- Pilots (21)